Long-term comparison of beta-interferons and azathioprine in relapsing remitting MS

Comparative data for therapies in multiple sclerosis (MS) are scarce. Researchers from the Department of Neuroscience, University of Florence, Italy, have retrospectively compared long-term outcomes between patients treated with beta-interferons (IFNs) or azathioprine (AZA) in relapsing remitting MS and find the treatment options to be equally effective in terms of disability outcomes and annualized relapse rate.